On September 13, 2023, Myovant Sciences, Ltd. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors that were Myovant common shareholders of record as of the close of business on January 20, 2023 (“Class Period”), which was the record date for determining the Minority Myovant Shareholders entitled to vote on the Merger.
We use cookies to improve your overall web experience. By using our website, you consent to the use of cookies in accordance with our Privacy Policy.